Peerbridge Health develops an advanced AI-driven ECG platform and a patented 3-lead, 2-channel wireless AECG patch called the Peerbridge Cor. The Cor is designed on Einthoven’s Triangle to mirror traditional 12-lead Holter placement and emphasizes superior recording fidelity, P-wave definition, and QRS morphology. The company combines the wearable hardware with proprietary algorithms and AI to detect and predict chronic illnesses such as heart failure, obstructive sleep apnea, and diabetes. Peerbridge plans to accelerate development and deployment of its remote diagnostic platform to help physicians identify potential and current health issues earlier, enabling earlier interventions and better outcomes. The company announced a $10 million funding round led by Mendota Venture Capital and HealthX Ventures to support that expansion. Leadership says the funding will help rapidly expand the platform and bring the technology to more patients and providers to improve care and reduce costs. Peerbridge Health develops Peerbridge Cor, a multi-channel wireless ECG patch that adheres to the chest for continuous monitoring. The device was cleared in 2017, can be worn up to seven days, and classifies 26 types of arrhythmia indications. Patients can manually transmit events via an app; all data pass through the company’s cloud network and algorithms before reaching providers and medical records. The company says the device can be reimbursed under common ECG tests and is approved under certain insurance codes. Peerbridge plans to use new funds to scale sales and operations and to advance strategic partnerships and M&A activity in 2020. It is also pursuing expanded reimbursement qualifications for its monitoring platform to grow adoption. Peerbridge Health is developing a medical-grade wearable sensor and an analytics platform to monitor vital signs. It uses sensors to track vital signs and aggregates and analyzes that data for medical professionals, athletes and sports coaches. The company is pursuing FDA 510(k) clearance for its wearable device. According to a Form D filing, Peerbridge has raised $1 million, and the filing suggests that sum could be the first portion of a larger raise potentially up to $50 million. Calls to the company to confirm the larger target were not returned. As noted in the article, industry observers warn adoption is early-stage; Mercom Capital Group Cofounder and CEO Raj Prabhu said, "the market is still in very early stages, and adoption of these wearables by caregivers to continuously monitor and treat patients is still far away."

Total raised

$22M

Funding rounds

3

Latest round

Equity

Latest activity

Mar 2023